novo nordisk glp-1 receptor agonists weight management diabetes treatments In the original clinical trials looking at semaglutide (the in Nordisk's Ozempic and Wegovy) and tirzepatide (in Eli Lilly's Mounjaro and Zepbound), patients gained back most of the after GoodRx announced that it will

Antidiabetic agents for treatment of Parkinsons disease: a meta-analysis

This new study adds to a growing body of evidence that GLP-1 medicines may play a role in lowering dementia risk. After applying matching methods to control for confounding factors, the study included over 174,000 patients, evenly divided between the two treatment groups

The definition of an ocular complication also varied in severity

However, in specifically designed placebo-controlled studies of GLP-1 RAs among patients with HFrEF, there were no improvements in HRQoL

The glucagon-like peptide-1 receptor as a potential treatment target in alcohol use disorder: Evidence from human genetic association studies and a mouse model of alcohol dependence

This initially seemed problematic for a weight loss medication